Evidence map›Paper›PMID 27376135›Full record

ReviewBladder cancer (Amsterdam, Netherlands)2016

Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.

Guilherme Godoy, Georgios Gakis, Carolyn L Smith, Omar Fahmy

Open access · hybridAbstract readReview
In one paragraph

Review in Bladder cancer (Amsterdam, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. The influence of sex hormones on renal cell carcinoma.Therapeutic advances in medical oncology · 2024
    Review
  8. Review
  9. Immunohistochemical analysis of sex hormone receptors in squamous changes of the urothelium.International journal of clinical and experimental pathology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Guilherme GodoyScott Department of Urology, Baylor College of Medicine , Houston, TX, USA.
Georgios GakisDepartment of Urology, Eberhard-Karls University , Tuebingen, Germany.
Carolyn L SmithScott Department of Urology, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Omar FahmyDepartment of Urology, Eberhard-Karls University , Tuebingen, Germany.
Baylor College of Medicine · USUniversity of Tübingen · DE

Funding

ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCERK23CA160664 · NCI · BAYLOR COLLEGE OF MEDICINE · PI GODOY, GUILHERME · 2013 to 2016
$541k
Antiestrogen Regulation of Bladder CancerR03CA119271 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SMITH, CAROLYN LOUISE · 2008 to 2009
$154k
NCI NIH HHS K23 CA160664NCI NIH HHS R03 CA119271
6 · The paper itself

Abstract

Epidemiologic studies have long demonstrated clear differences in incidence and progression of bladder cancer between genders suggesting that the mechanisms of development and progression in these tumors have a strong association with steroid hormonal pathways. Such observations led to preclinical studies investigating the role of androgen and estrogen receptors, as well as their cognate hormones in bladder cancer initiation and progression. Using various

Indexed as

androgenandrogen antagonistsAndrogenscarcinogenesisdisease progressionestrogenestrogen receptor modulatorsestrogensreceptorreceptorsurinary bladder neoplasms

Identifiers

PMID27376135
PMCPMC4927898
OpenAlexW2343209773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.